This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Motoyama S, Jin M, Matsuhashi T, et al. Outcomes of patients receiving additional esophagectomy after endoscopic resection for clinically mucosal, but pathologically submucosal, squamous cell carcinoma of the esophagus. Surg Today. 2013;43:638–42.
Ikeda A, Hoshi N, Yoshizaki T, et al. Endoscopic submucosal dissection (ESD) with additional therapy for superficial esophageal cancer with submucosal invasion. Intern Med. 2015;54:2803–13.
Koterazawa Y, Nakamura T, Oshikiri T, et al. A comparison of the clinical outcomes of esophagectomy and chemoradiotherapy after noncurative endoscopic submucosal dissection for esophageal squamous cell carcinoma. Surg Today. 2018;48:783–9.
Minashi K, Nihei K, Mizusawa J, et al. Efficacy of endoscopic resection and selective chemoradiotherapy for stage I esophageal squamous cell carcinoma. Gastroenterology. 2019;157:382-90.e3.
Maruyama S, Okamura A, Imamura Y, et al. Comparison of outcomes between additional esophagectomy after noncurative endoscopic resection and upfront esophagectomy for T1N0 esophageal squamous cell carcinoma. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-020-09498-z.
Suguru Maruyama, Akihiko Okamura, and Masayuki Watanabe have declared no conflicts of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Maruyama, S., Okamura, A. & Watanabe, M. ASO Author Reflections: Additional Esophagectomy After Noncurative Endoscopic Resection Versus Upfront Esophagectomy in Patients with T1N0 Esophageal Squamous Cell Carcinoma. Ann Surg Oncol (2021). https://doi.org/10.1245/s10434-020-09502-6